Journal of Medicinal Chemistry p. 1003 - 1020 (2016)
Update date:2022-08-15
Topics:
Demont, Emmanuel H.
Bailey, James M.
Bit, Rino A.
Brown, Jack A.
Campbell, Colin A.
Deeks, Nigel
Dowell, Simon J.
Eldred, Colin
Gaskin, Pam
Gray, James R. J.
Haynes, Andrea
Hirst, David J.
Holmes, Duncan S.
Kumar, Umesh
Morse, Mary A.
Osborne, Greg J.
Renaux, Jessica F.
Seal, Gail A. L.
Smethurst, Chris A.
Taylor, Simon
Watson, Robert
Willis, Robert
Witherington, Jason
FTY720 is the first oral small molecule approved for the treatment of people suffering from relapsing-remitting multiple sclerosis. It is a potent agonist of the S1P1 receptor, but its lack of selectivity against the S1P3 receptor ha
View MoreHenan PURUI Pharmaceutical Co., Ltd.
website:http://www.puruipharm.com
Contact:17739583555
Address:Yezhuangqiao,Xihua town, Henan province
TIANJIN FESTO CHEMICAL CO.,LTD(expird)
Contact:86-22-25814570
Address:No.12th,5th Ave.,TEDA,Tianjin,China
website:http://www.alwaychem.com
Contact:+86-532-8586-4000, 8586-5000
Address:NO.51, TAIPING ROAD, QINGDAO, CHINA. 266001
Nanjing Ruizhi Industry & Technologh Co.,Ltd.
Contact:+86-25-86808110
Address:441-4-A5,NO.12 Longzang Avenue,Yuhuatai District,210039,Nanjing
website:http://www.lonwinchem.com
Contact:Tel: 86-21-59858395
Address:No#966,Huaxu Road,Shanghai 201702,P.R.China
Doi:10.1016/j.tetlet.2010.09.062
(2010)Doi:10.1021/ma102386j
(2011)Doi:10.1039/c0cc03004j
(2010)Doi:10.1016/S0040-4039(00)99258-X
(1989)Doi:10.1016/j.bmcl.2010.09.138
(2010)Doi:10.1007/s10593-014-1425-3
(2014)